We appreciate the opportunity to discuss predictive diagnostics for periodontal diseases further than was possible in our original Primer (Periodontal diseases. Nat. Rev 2 . Quantitative diagnostic tests, such as the one the authors propose, which measures the levels of activated matrix metalloproteinase 8 (aMMP8) as a biomarker of active perio dontal disease, are welcome new tools and could enhance screening for periodontal disease as well as aid diagnosis and prognostic assessment. However, moreextensive independent verification and a plausible biological argument that supports the role of the selected biomarker in the aetiopathogenesis of periodontal disease are needed before these tests can be recommended for clinical practice 3 . Molecular diagnostics in periodontal disease are to be encouraged, but not prematurely adopted, as occurred with the IL-1 genotype-based diagnostic test [4] [5] [6] . The IL-1-based genetic test was heavily marketed despite multiple studies that questioned its diagnostic utility 3, 4 and weak and contradictory elements in the supporting literature 6 . MMP8 is a ubiquitous inflammatory molecule, and inflammation contributes to both disease initiation and the healing process. Thus, aMMP8 would have a pivotal role in all phases of inflammation, which would hinder its predictive value 3 . Despite the many potential markers and tests that exist, only a few have verified clinical usefulness, and the Primer provides a balanced overview of those with proven utility or promise.
